SOPH Sale Disclosure
Puylaert Kevin · SEC Form 4 · Filed Oct 7, 2026
Sale
Calculated transaction value
$245.52
Puylaert Kevin Chief Sales Officer
SOPH
Transaction date
Oct 5, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed 2 days later
SOPH daily price context
Close on/before transaction
$8.2
Oct 5, 2026
First close after public filing
$7.3
Oct 8, 2026
Return after filing · so far
+1.51%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 31 shares @ $7.92
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001840706-26-000333
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$1.74K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Sophia Genetics Sa SOPH Current | Sale | Oct 5, 2026 | $245.52 |
| Sophia Genetics Sa SOPH | Sale | Oct 5, 2026 | $1.49K |